Wealth Enhancement Advisory Services LLC Grows Stock Position in Teleflex Incorporated $TFX

Wealth Enhancement Advisory Services LLC raised its position in Teleflex Incorporated (NYSE:TFX) by 113.9% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 58,047 shares of the medical technology company’s stock after buying an additional 30,912 shares during the quarter. Wealth Enhancement Advisory Services LLC owned about 0.13% of Teleflex worth $7,366,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB lifted its position in Teleflex by 57.9% in the third quarter. MassMutual Private Wealth & Trust FSB now owns 210 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 77 shares during the period. Quent Capital LLC purchased a new position in shares of Teleflex during the 3rd quarter worth approximately $38,000. True Wealth Design LLC lifted its holdings in shares of Teleflex by 10,333.3% in the 2nd quarter. True Wealth Design LLC now owns 313 shares of the medical technology company’s stock valued at $37,000 after buying an additional 310 shares during the period. Salomon & Ludwin LLC purchased a new stake in shares of Teleflex in the third quarter valued at approximately $49,000. Finally, Farther Finance Advisors LLC grew its holdings in Teleflex by 151.9% during the third quarter. Farther Finance Advisors LLC now owns 408 shares of the medical technology company’s stock worth $50,000 after acquiring an additional 246 shares during the period. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on TFX. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Tuesday, December 9th. Royal Bank Of Canada restated a “sector perform” rating and issued a $135.00 price target on shares of Teleflex in a report on Wednesday, December 17th. Truist Financial upped their price objective on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research report on Thursday, December 18th. Finally, Wells Fargo & Company upped their price objective on shares of Teleflex from $114.00 to $139.00 and gave the company an “equal weight” rating in a research note on Wednesday, December 10th. One equities research analyst has rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus price target of $142.43.

Teleflex Stock Down 1.6%

TFX opened at $103.40 on Friday. Teleflex Incorporated has a 1 year low of $100.18 and a 1 year high of $185.94. The firm has a 50 day moving average price of $116.27 and a 200 day moving average price of $120.02. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. The company has a market cap of $4.57 billion, a PE ratio of -14.07, a price-to-earnings-growth ratio of 1.35 and a beta of 0.93.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The company had revenue of $892.90 million during the quarter, compared to the consensus estimate of $892.79 million. During the same period in the previous year, the firm earned $3.49 earnings per share. Teleflex’s revenue for the quarter was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date was Friday, November 14th. Teleflex’s dividend payout ratio is currently -18.50%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.